Latest Inferior vena cava Stories

Consumers can contact Resource4thePeople's national network of attorneys for free consultations about their legal options to join with those seeking compensation for alleged side effects, including deep vein thrombosis, filter fracture, migration and perforation. San Diego, CA (PRWEB) May 11, 2013 http://www.resource4thepeople.com/defectivemedicaldevices/bard-ivc.html Resource4thePeople announced today a consumer update of the progress of litigation involving claims that patients who...

SAN ANTONIO, May 1, 2013 /PRNewswire/ -- BiO2 Medical, Inc., a Texas based medical device manufacturer with corporate offices in San Antonio, Texas, and R&D and manufacturing operations in Golden, Colorado, is among the first to receive U.S. Food and Drug Administration (FDA) approval of their Investigational Device Exemption (IDE) application to begin an Early Feasibility Pilot Study (EFPS) using the Angel(TM) Catheter. The Angel(TM) Catheter is the first to combine the...

Inferior vena cava filter placement One venous puncture, rather than two, is a safe and effective approach to intravascular ultrasound-guided inferior vena cava filter placement in critically-ill patients, a new study shows. Inferior vena cava filter placement is done to prevent or treat pulmonary emboli or deep venous thrombosis. "The majority of institutions use a dual venous puncture technique, while we use a single venous puncture technique," said Dr. Andrew Gunn, of Massachusetts...

Current consumer inquiries about legal rights over alleged problems with medical devices are among those being accepted for Resource4thePeople’s free legal consultations to patients who are alleging serious health problems. San Diego, CA (PRWEB) April 18, 2013 Resource4thePeople announced today that it will accept 2013 claims from consumers who are alleging that they may have suffered serious side effects as a result of having Bard IVC Filters implants. The side effects being...

As the number of inquiries from concerned consumers increases, Resource4thePeople announces free consultations to evaluate allegations from patients who may have suffered serious health problems involving alleged failures of Bard IVC Filters. San Diego, CA (PRWEB) March 08, 2013 http://www.resource4thepeople.com/defectivemedicaldevices/bard-ivc.html Resource4thePeople announced today that its attorneys are now investigating claims from victims who allegedly may have suffered serious...

Resource4thePeople providing referrals to free consultations offering evaluation of legal options as new study of IVC filter is announced San Diego CA (PRWEB) February 18, 2013 Resource4thePeople announced today that it is now providing referrals to lawyers offering free consultations to victims who allegedly may have suffered serious health problems as a result of Bard IVC Filter failures. This announcement stems in part from the recent announcement by The Society of Interventional...

MENLO PARK, Calif., Jan. 23, 2012 /PRNewswire/ -- Crux Biomedical announced it has received CE mark approval for their revolutionary inferior vena cava filter (IVCF) with bi-directional retrieval (BDR). Vena cava filters are designed to trap blood clots that can lead to a potentially fatal pulmonary embolism (PE). Each year in the United States, approximately 600,000 patients develop a PE and an estimated 200,000 deaths occur. The Crux Biomedical IVCF was designed to address the...

Journal of Vascular and Interventional Radiology includes largest single patient population study to date on placement success, patient follow-up Researchers have published the largest single patient population study to date on a method for following patients with retrievable inferior vena cava (IVC) filters—devices used to keep blood clots from traveling to the lungs. This study, which is important for individuals with IVC filters and their doctors, supports existing guidelines...

Journal of Vascular and Interventional Radiology Includes Largest Single Patient Population Study to Date on Placement Success, Patient Follow-up FAIRFAX, Va., Nov. 28, 2011 /PRNewswire-USNewswire/ -- Researchers have published the largest single patient population study to date on a method for following patients with retrievable inferior vena cava (IVC) filters--devices used to keep blood clots from traveling to the lungs. This study, which is important for individuals with IVC...

MENLO PARK, Calif., Sept. 28, 2011 /PRNewswire/ -- Crux Biomedical, developer of an advanced implantable vena cava filter (IVCF) to prevent pulmonary embolisms, announced the appointment of Randy Lindholm as the Company's Chairman of the Board. Mr. Lindholm has served on the Company's Board of Directors since March 2011. Mr. Lindholm was previously Chairman of the Board and CEO of Vidamed, a maker of minimally invasive medical devices to treat benign prostate hyperplasia until it was...